NCT02026388

Rare Kidney Stone Consortium Biobank

Rare Kidney Stone Consortium Biobank, Rare Diseases Clinical Research Network

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

Detailed description

Biologic samples will be stored in the biobank from well characterized patients with primary hyperoxaluria, cystinuria, APRT deficiency, and Dent disease, and from their family members, for use in future research. This will help to advance our understanding of disease expression and the factors associated with kidney injury in these four diseases with the overall goal of developing new treatments to preserve kidney function and reduce nephrocalcinosis and stone formation.

Conditions

• Primary Hyperoxaluria
• Dent Disease
• APRT Deficiency
• Cystinuria

Timeline

• Start date: 2013-05-01
• Primary completion: 2030-06-01
• Completion: 2030-06-01
• First posted: 2014-01-03
• Last updated: 2025-07-22

Locations

1 site across 1 country: United States